Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
may form part of the selection process. Project: Access Universal Design Project For an information package including full details of the post, selection criteria and application process see https
-
project is an interdisciplinary, design-led research programme focused on improving antenatal colostrum collection and hand expression practices for expectant parents. It combines participatory design
-
5 Months Fixed-Term, Whole-time Post The postdoctoral researcher will work within the Universal Design Unit. The unit is currently being established to embed Universal Design across all domains
-
10 Months Fixed Term, Part-time Post (0.5 FTE) The FirstDrops project is an interdisciplinary, design-led research programme focused on improving antenatal colostrum collection and hand expression
-
innovation for dermal generics and advanced skin therapies guideSkin is an EU-funded MSCA Industrial Doctoral offering 15 fully funded PhD positions at the cutting edge of cutaneous drug development. Brining
-
, University College Cork is undertaking an innovative mixed-methods research project examining antidepressant prescribing and deprescribing practices in Irish primary care. Funded through the HSE Consultant
-
9 Months Fixed-Term, Part-Time Post (0.8 FTE) The Department of Psychiatry, University College Cork is undertaking an innovative mixed-methods research project examining antidepressant prescribing
-
advancing quantum computing. The project is funded by Enterprise Ireland through the Disruptive Technologies Innovation Fund (DTIF). The successful candidate will contribute to the "Quantum Computing
-
innovation for dermal generics and advanced skin therapies guideSkin is an EU-funded MSCA Industrial Doctoral offering 15 fully funded PhD positions at the cutting edge of cutaneous drug development. Brining
-
innovation for dermal generics and advanced skin therapies guideSkin is an EU-funded MSCA Industrial Doctoral offering 15 fully funded PhD positions at the cutting edge of cutaneous drug development. Brining